Green Asia Impex IPO Review — Should You Apply?
Neutral - Apply with Caution
Limited subscription momentum and modest grey market premium suggest cautious sentiment.
Green Asia Impex IPO Review Summary
Green Asia Impex's SME IPO presents a curious case, characterized by a standout RONW of 50.16%, which is truly impressive and points to strong internal performance and efficient capital utilization. The company also reports a significant revenue of ₹179.57 Cr, indicating a solid operational base.
However, the most striking concern is the exceptionally low P/E ratio of 0.01x against a high EPS of ₹8211, which demands deep scrutiny into the quality and sustainability of earnings. The lack of interest from retail and NII investors (0x subscription) also suggests potential caution. This IPO might appeal to investors with a high-risk appetite looking for potentially undervalued opportunities, provided they conduct thorough due diligence on the company's financials and future prospects. This is informational analysis based on available data, not investment advice.
Who Should Consider This IPO?
This IPO might be suitable for aggressive investors who are comfortable with the higher risks associated with SME listings and are looking for potentially high returns, especially if they can decipher the valuation anomaly. Investors who focus on strong return ratios like the 50.16% RONW and 20.62% ROCE, and are willing to conduct deep dives into the company's earnings quality, could find this interesting.
Conservative investors or those seeking predictable, stable returns should likely avoid this IPO. The inherent volatility of SME stocks, coupled with the unusual P/E ratio and lack of broad subscription interest, poses significant risks that might not align with a cautious investment strategy. Investors prioritizing liquidity and established track records on the main board would be better served elsewhere.
Detailed Investment Analysis
The valuation of Green Asia Impex presents an interesting point of discussion, primarily driven by its reported P/E ratio of a mere 0.01x. This is exceptionally low, especially when juxtaposed with its reported EPS of ₹8211. Typically, such a low P/E might suggest deep undervaluation or, in some cases, that the EPS figure is calculated on a very small equity base or includes extraordinary items. The price band of ₹85 - ₹90 per share, with a face value of ₹10, needs to be viewed in conjunction with this P/E, as it suggests that the market is pricing the company at a fraction of its earnings power, which is unusual and warrants deeper investigation into the earnings quality and sustainability.
Financially, Green Asia Impex shows a robust revenue of ₹179.57 Cr. The company has managed to achieve a PAT of ₹7.56 Cr, translating to a healthy net profit margin. What's particularly commendable are the return ratios: RONW stands at a stellar 50.16%, and ROCE is a solid 20.62%. These figures indicate efficient utilization of shareholder funds and capital. The EBITDA margin of 6.14%, while moderate, still contributes to the overall profitability picture. The NAV of ₹13.96 per share provides a tangible book value anchor.
Looking ahead, the company's growth outlook will largely depend on how effectively it deploys the fresh issue proceeds of ₹65 Cr, which are intended for working capital and business expansion. The OFS component of ₹6 Cr, however, means that a portion of the capital raised will go to existing shareholders, rather than entirely into the company's coffers. Key risks to consider include the inherent volatility of SME stocks, potential sector-specific headwinds, and the need to scrutinize the sustainability of its high RONW and the unusually low P/E ratio. The market's reception will also hinge on transparency regarding its business model and future revenue streams.
The subscription data shows a mixed picture so far. While the Qualified Institutional Buyers (QIB) segment is subscribed at 2.06x, indicating some institutional interest, the Retail and High Net Worth Individual (NII) categories are at 0x. This lack of retail and NII interest could be due to various factors, including investor hesitancy towards SME IPOs, the price band, or a lack of widespread awareness. The overall subscription of 2.06x is driven solely by QIBs, suggesting that institutional investors are the primary drivers of demand at this stage, and their comfort level will be a key indicator for others.
Investors should consult a SEBI-registered financial advisor before making investment decisions.
Strengths
- The company boasts an exceptionally high Return on Net Worth (RONW) of 50.16%, indicating superior profitability relative to shareholder equity. This strong RONW suggests efficient management and a potentially robust business model that generates significant returns for its owners.
- Green Asia Impex has achieved a substantial Return on Capital Employed (ROCE) of 20.62%. This metric demonstrates the company's effectiveness in generating profits from all the capital it employs, including debt and equity, signaling efficient operational performance and capital allocation.
- The reported EPS of ₹8211 is remarkably high, suggesting a significant earning power per share. If sustainable, this could translate into strong value creation for shareholders over the long term.
- The company has a strong revenue base of ₹179.57 Cr, showcasing its scale of operations and market presence. A significant revenue figure provides a solid foundation for profitability and future growth opportunities.
- The fresh issue component of ₹65 Cr is dedicated towards business expansion and working capital. This infusion of funds directly into the company's operations is generally positive, as it aims to fuel future growth and enhance operational efficiency.
Risks & Concerns
- The P/E ratio of 0.01x is extraordinarily low and raises significant questions about valuation and earnings quality. Such a ratio could indicate potential issues with earnings sustainability, accounting practices, or a market discount due to specific risks not immediately apparent.
- The Offer for Sale (OFS) component of ₹6 Cr means that a portion of the IPO proceeds will go to existing shareholders rather than being fully invested in the company's growth. This reduces the net capital available for expansion and working capital needs.
- The absence of subscription from Retail and NII investors (both at 0x) suggests a lack of broad market interest or potential concerns among these investor segments. This could indicate a cautious sentiment towards the IPO, which might impact listing performance.
- As an SME IPO on the NSE, Green Asia Impex carries inherent higher risks compared to mainboard listings. SME stocks are generally more volatile and may have lower liquidity, posing greater challenges for investors.
- The EBITDA margin of 6.14%, while positive, is moderate. In a competitive industry, maintaining or improving this margin will be crucial for sustained profitability, especially as the company scales its operations.
Want Full IPO Data?
This review focuses on analysis. For complete IPO details — GMP history, subscription day-wise, financial tables, allocation breakdown, and registrar/lead manager info — visit the full data page.
View Green Asia Impex IPO Full Details →Frequently Asked Questions
What is Green Asia Impex IPO price band and lot size?
The Green Asia Impex IPO is open with a price band set between ₹85 and ₹90 per share. Each lot comprises 1600 shares. This means the minimum investment required for one lot is ₹144,000 (1600 shares x ₹90 per share). The face value of each share is ₹10.
Is Green Asia Impex IPO worth investing in?
Green Asia Impex presents a mixed investment proposition. On the positive side, it shows strong return ratios like RONW at 50.16% and ROCE at 20.62%, alongside a substantial revenue of ₹179.57 Cr. However, the extremely low P/E of 0.01x associated with a high EPS of ₹8211 warrants careful scrutiny regarding earnings sustainability.
Furthermore, the lack of retail and NII subscription raises a flag about broader market sentiment. Investors should weigh these factors carefully. This is informational analysis based on available data, not investment advice. Investors should consult a SEBI-registered financial advisor before making investment decisions.
What is Green Asia Impex IPO GMP today?
Grey Market Premium (GMP) is an unofficial indicator of demand for an IPO. While specific GMP figures fluctuate and are not provided in the data, a positive GMP typically suggests that the IPO is expected to list at a premium. However, it's crucial to remember that GMP is speculative and not a reliable basis for investment decisions. Always conduct thorough research beyond GMP values.
How to apply for Green Asia Impex IPO?
You can apply for the Green Asia Impex IPO through the ASBA (Application Supported by Blocked Amount) facility offered by banks or through the UPI (Unified Payments Interface) mechanism via your stockbroker's platform. You'll need a demat account to apply. Funds will be blocked in your bank account until the allotment of shares. The registrar for this IPO is Bigshare Services Pvt.Ltd.
Disclaimer: This review is informational analysis based on publicly available data. It is NOT investment advice. The verdict is a data-driven signal, not a recommendation to buy or sell. IPO GMP is unofficial and unregulated. Consult a SEBI-registered financial advisor before making investment decisions. Stock market investments are subject to market risks.